Drug intelligence / Profile preview

red yeast rice + salvia miltiorrhiza + ganoderma lucidum

Development stage
Unknown
Lead developer
Zhejiang Fangge Pharmaceutical Industry
Modality
Small Molecules
Administration
Oral
01

Overview

Red yeast rice + salvia miltiorrhiza + ganoderma lucidum is a natural product combination capsule developed and manufactured by Zhejiang Fangge Pharmaceutical. This oral formulation is primarily used for the management of hyperlipidemia and the promotion of cardiovascular health. The therapeutic effect is largely attributed to monacolins (such as monacolin K) present in the red yeast rice, which function as HMG-CoA reductase inhibitors to lower endogenous cholesterol production. *Salvia miltiorrhiza* (Danshen) provides additional benefits through its anti-inflammatory and anti-platelet activities, which help improve blood flow and protect the vascular endothelium. *Ganoderma lucidum* (Lingzhi) contributes immunomodulatory and antioxidant properties, supporting overall metabolic health. The product is approved in China as a health supplement (often referred to as a Blue Hat product) for regulating blood lipids.

Brand names
Fangge Brand Hongqu Danshen Lingzhi Capsules
Other names
red yeast rice / salvia / ganoderma capsuleHongqu Danshen Lingzhi Capsule
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on red yeast rice + salvia miltiorrhiza + ganoderma lucidum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on red yeast rice + salvia miltiorrhiza + ganoderma lucidum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call